Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Govindaswami Ragupathi"'
Autor:
David Verbel, Samuel J. Danishefsky, Dalibor Sames, Susan F. Slovin, Govindaswami Ragupathi, Philip O. Livingston, Howard I. Scher, Cristina Musselli, Krystyna Olkiewicz, Scott D. Kuduk, Jacob B. Schwarz
Publikováno v:
Journal of Clinical Oncology. 21:4292-4298
Purpose: We report the synthesis of a mucin-related O-linked glycopeptide, α-N-acetylgalactosamine-O-serine/threonine (Tn), which is highly simplistic in its structure and can induce a relevant humoral response when given in a trimer or clustered (c
Autor:
Yael Spinat, Teresa Gilewski, Govindaswami Ragupathi, Katherine S. Panageas, Philip O. Livingston, Cristina Musselli
Publikováno v:
International Journal of Cancer. 97:660-667
Conjugation of antigens to a carrier protein like keyhole limpet hemocyanin (KLH) has proven effective in clinical trials for inducing antibodies against selected tumor antigens. The impact of this approach on T-cell immunity has not been previously
Keyhole limpet hemocyanin conjugate vaccines against cancer: The Memorial Sloan Kettering experience
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 127:R20-R26
Passively administered and actively induced antibodies have been associated with the eradication of circulating tumor cells and micrometastases in mice and humans. We have identified a series of cell surface carbohydrate and peptide antigens on melan
Autor:
Jennifer R. Allen, Allen John Gordon, Andrzej Zatorski, Philip O. Livingston, Govindaswami Ragupathi, Xu-Feng Zhang, Samuel J. Danishefsky, Lawrence J. Williams
Publikováno v:
Chemistry - A European Journal. 6:1366-1375
A new synthesis of the hexasaccharide MBr1 antigen (globo-H) is reported. A revised construction with improved efficiency was necessary because an anti-cancer vaccine containing this antigen is entering phase II and phase III clinical trials for pros
Autor:
Govindaswami Ragupathi, Lawrence J. Williams, Maria Spassova, Valery Kudryashov, William Bornmann, Susan F. Slovin, Xufang Zhang, Andrzej Zatorski, Howard I. Scher, Philip O. Livingston, Zhugang Wang, Kenneth O. Lloyd, Samuel J. Danishefsky
Publikováno v:
Proceedings of the National Academy of Sciences. 97:2719-2724
We have previously reported on a carbohydrate-based vaccine program for immunotherapy in cancer patients. One such vaccine, based on the globo H antigen conjugated to the protein keyhole limpet hemocyanin (KLH), has been in clinical evaluation. Altho
Autor:
John Curtin, Catherine O'Flaherty, Philip O. Livingston, Andrzej Zatorski, Maria Spassova, William G. Bornmann, Govindaswami Ragupathi, Paul Sabbatini, David Spriggs, Madeline Peyton, Valery Kudryashov, Carol Aghajanian, Kenneth O. Lloyd, Samuel J. Danishefsky, Steven L. Soignet
Publikováno v:
International Journal of Cancer. 87:79-85
As the initial step in developing carbohydrate-based vaccines for the treatment of ovarian cancer patients in an adjuvant setting, 25 patients were immunized with a Lewisy pentasaccharide (Ley)-keyhole limpet hemocyanin (KLH)-conjugate vaccine togeth
Publikováno v:
Journal of Clinical Immunology. 20:85-93
There is now a considerable body of information documenting the autoimmune consequences of antibodies induced by growing malignancies, or by passively administered and actively induced antibodies, in cancer patients against antigens shared by normal
Autor:
Cristina Musselli, Philip O. Livingston, Govindaswami Ragupathi, Fred-Thomas Brezicka, Nancy X. Liu, Sarah Cappello
Publikováno v:
Cancer Immunology, Immunotherapy. 48:483-492
Fucosyl-GM1 (Fuc-GM1) [Fucalpha1 --2Galbeta1 --3GalNAcbeta1 --4(NeuAcalpha2-3)Galbeta1 --4Glcbeta1 --O-Cer] is a small-cell-lung-cancer (SCLC)-associated ganglioside initially defined by the murine monoclonal antibody F12. On the basis of its known d
Autor:
Samuel J. Danishefsky, Hyunjin M. Kim, Sucharita Adluri, Govindaswami Ragupathi, Howard I. Scher, Kenneth O. Lloyd, Susan F. Slovin, William G. Bornmann, Philip O. Livingston, Maria Spassova, Dalibor Sames, In Jong Kim
Publikováno v:
Angewandte Chemie International Edition. 38:563-566
Human trials on the globo H carbohydrate vaccine (see picture, KLH=the carrier protein keyhole limpet hemocyanin) show that it produces strong IgM, and in some cases IgG, responses in patients with progressive and recurrent prostate cancer. Furthermo
Autor:
Susan F. Slovin, Samuel J. Danishefsky, Howard I. Scher, Govindaswami Ragupathi, Dalibor Sames, Philip O. Livingston, Hyunjin M. Kim, In Jong Kim, William G. Bornmann, Kenneth O. Lloyd, Sucharita Adluri, Maria Spassova
Publikováno v:
Angewandte Chemie. 111:590-594